This article was originally published here
Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19882. Online ahead of print.
Psoriasis (Ps) is a chronic, immune-mediated skin disease with systemic involvement. Therapeutic advancements in its management have considerably improved disease activity and quality of life, and reduced hospitalization rates. Nevertheless, prolonged immunosuppression in psoriatic patients may increase their susceptibility to opportunistic infections.